Enhancement of the inhibitory effect of g-aminobutyric acid (GABA) acting on its type A receptor in the mammalian brain explains the pharmacological and therapeutic actions of benzodiazepines which bind to a specific site in the GABA A receptor. However, the usefulness of benzodiazepines as anxiolytics, sedatives, anticonvulsants and muscle relaxants is compromised by the occurrence of several adverse effects such as ataxia, amnesia, alcohol intolerance, and residual sedation, as well as the related problems of tolerance and dependence after chronic use. Molecular biology studies have established the heterogeneity of GABA A receptors and the pharmacological and electrophysiological study of the different subtypes has allowed the search of new ligands with improved selectivity which eventually may lead to the development of safer drugs.
Preparation of Extract
Fossilia Mastodi OSSIS, a Chinese herbal powder, was purchased from Electronic KyungDong Market (EKD, Seoul, Korea), which guarantees the quality of the herb according to the guidelines of the Korean Pharmacopoeia (KP). Dried powder was extracted two times with 80% methanol for 3 h. The solvent was then removed at low temperature under reduced pressure. The extracts were resuspended in normal saline and stored at Ϫ20°C for pharmacological studies.
Elevated Plus Maze Test
This test has been validated to measure anxiety in rodents. 12, 13) The maze is a horizontal cross made by two open platforms of 25 cmϫ5 cm crossed by two platforms of the same dimensions, closed by walls 35 cm high. The maze is suspended 50 cm from the room floor. Experiment 1: Effect of extract or diazepam in the elevated plus maze: The extract or diazepam (0.5 mg/kg, i.p.) was administered to independent groups of mice (nϭ8, each) and tested in the elevated plus maze. In this case, diazepam dissolved in propylene glycol was used as a positive control group. Control mice for the extract-treated group were administered saline per os, and control mice for the diazepamtreated group were given propylene glycol intraperitoneally. Control data from both groups of mice were not significantly different.
Experiment 2: Analysis of the participation of the GABA A receptor complex in the anxiolytic-like actions of extract in the elevated plus maze: For this experimental series, independent groups of mice (nϭ5-24, each) were used. In the first part of this experiment, the effects of picrotoxin or muscimol alone were analyzed in the elevated plus maze. In the second part of this experiment, the GABA A receptor antagonist picrotoxin (0.5 mg/kg) was simultaneously administered with extract to mice tested in the elevated plus maze. Finally, in the third part, possible synergism of the anxiolytic-like actions of extract with muscimol (0.5 mg/kg) and of extract simultaneously administered to mice was analyzed in the elevated plus maze.
Sodium Pentobarbital-Induced Sleeping Time In this test the time, in minutes, elapsing from the loss to the regaining of the righting reflex after drug administration is recorded and referred to as sleeping time. The hypnotic effect of extract in combination with sodium pentobarbital was evaluated. For this purpose, mice were divided into three groups (nϭ8, each). The first group served as control and was injected with the vehicle, while the 2nd group received the extract 30 min before the administration of an effective dose of sodium pentobarbital (42 mg/kg, i.p.). The last group was administered diazepam (1.0 mg/kg) 30 min before the administration of pentobarbital. This last group served as a positive control. In the second part of the experiment, mice were treated with the extract or diazepam (1.0 mg/kg, Ϫ30 min) before the administration of a subthreshold dose of pentobarbital (30 mg/kg).
Assay for Locomotor Activity Mice were divided randomly into 3 groups of 8 animals each. One group was given the extract at a single dose of 3 g/kg per os. Mice in the 2nd and 3rd groups received diazepam (5 mg/kg) and normal saline, respectively. Thirty minutes after administration, the animals were transferred to individual cages. Activity counts were measured for 60 min using video tracking (Smart, Panlab s.l., Barcelona, Spain).
Picrotoxin-Induced Clonic Convulsion The effects of compounds on picrotoxin-induced clonic convulsions were evaluated. Picrotoxin (7.5 mg/kg) was administered intraperitoneally to mice 30 min after extract or vehicle administration. The latency (min) of seizure onset and percent lethality were calculated.
Statistical Analysis Data are presented as the meanϮS.E. Intergroup comparisions of data were made by Student t-test (Systat, Intelligent Software, Evanston, IL, U.S.A.).
RESULTS
Mice administered an 80% methanol extract of Fossilia Mastodi OSSIS given per os at a dose of 3 g/kg showed anxiolysis. As shown in Fig. 1 , in the extract-treated mice, open crosses (%) were significantly (pϽ0.05) increased to 53.0Ϯ 1.5 from the control value of 45.2Ϯ1.6 and time in the open (%) was significantly (pϽ0.05) increased to 48.9Ϯ2.8 from the control value of 36.5Ϯ3.5. In a preliminary study, the optimal dose of the extract for this study could be obtained.
As shown in Fig. 2 , extracts reduced spontaneous motor activity in mice, the distance travelled (%) was significantly (pϽ0.05) decreased to 52.5Ϯ2.6 from 100% in control mice but was significantly (pϽ0.05) higher than the value (41.1Ϯ3.2) in the 5 mg/kg of diazepam treated mice. In a preliminary study, separate dose of diazepam suitable for each experiment could be obtained. As shown in Fig. 3 , the 80% methanol extract of Fossilia Mastodi OSSIS potentiated the pentobarbital-induced sleeping time. Groups treated with a hypnotic dose of pentobarbital, 42 mg/kg, intraperitoneally, showed more potentiation than groups treated with a subthreshold dose of pentobarbital (30 mg/kg). In the 42 mg/kg pentobarbital treated group, latency of sleeping time, in the Fossilia-treated group, was significantly (pϽ0.05) reduced to 3.5Ϯ0.2 from the control value of 8.5Ϯ0.3 and duration of sleeping time (min) was significantly (pϽ0.05) increased to 50.5Ϯ1.6 from the control value of 44.3Ϯ1.2. 43% of mice showed hypnosis by administration of a subthreshold dose (30 mg/kg) of pentobarbital. In the 30 mg/kg pentobarbital treated group, latency of sleeping time was significantly (pϽ0.05) reduced to 3.4Ϯ0.2 from the control value of 8.5Ϯ0.6 and duration of sleeping time (min) was significantly (pϽ0.05) increased to 96.3Ϯ2.6 from the control value of 52.8Ϯ1.6.
As shown in Fig. 3 , diazepam also potentiated the pentobarbital-induced sleeping time. Groups treated with a hypnotic dose of pentobarbital (42 mg/kg, i.p.), showed more potentiation than groups treated with a subthreshold dose (30 mg/kg) of pentobarbital. In the 42 mg/kg pentobarbital treated group, latency of sleeping time was significantly (pϽ0.05) reduced to 4.5Ϯ0.1 from the control value of 8.5Ϯ0.3 and the duration of sleeping time (min) was significantly (pϽ0.05) increased to 76.7Ϯ1.2 from the control value of 44.3Ϯ1.2. In the 30 mg/kg pentobarbital treated group, latency of sleeping time, was significantly (pϽ0.05) reduced to 1.0Ϯ0.1 from the control value of 8.5Ϯ0.6 and duration of sleeping time (min) was significantly (pϽ0.05) increased to 116.6Ϯ4.3 from the control value of 52.8Ϯ1.6.
As shown in Fig. 4 , the extract of Fossilia Mastodi OSSIS increased the latency (min) of picrotoxin-induced clonic convulsion in mice. In the Fossilia-treated group, latency (min) was significantly (pϽ0.05) increased to 10.0Ϯ0.9 from the control value of 7.5Ϯ0.6. However, the extract did not change the picrotoxin-induced lethality or myorelaxant activities in the horizontal-wire test (data not shown).
As shown in 
DISCUSSION
Benzodiazepines have an established efficacy in the treatment of anxiety, insomnia and epilepsy. They produce their pharmacological effects by positively modulating the action of GABA at GABA A receptors through an allosteric binding site called the benzodiazepine binding site. Even though benzodiazepines are relatively safe drugs when used in the treatment of pathological anxiety, they may produce untoward side effects such as sedation, muscle relaxation, memory impairment, tolerance and physical dependence. Recent work has shown that there is considerable heterogeneity of GABA A receptors. At least 15 different subunits have been identified in the mammalian CNS (a1-6, b1-3, g1-3, r1-2 and (1) and it is now widely acknowledged that the (1 subtype corresponds to GABA A receptors containing a1 subunit, while the w2 subtype represents a heterogeneous population of receptors possessing a2, a3 or a5 subunits. 14) Benzodiazepines, such as diazepam or bretazenil, act with high affinity at all receptor subtypes, However, diazepam exhibits high intrinsic efficacy, while bretazenil displays reduced efficacy and is therefore described as a partial agonist. Diazepam produces anticonvulsant, anxiolytic, muscle relaxant, and sedative effects, whereas bretazenil is mainly an an- ticonvulsant and anxiolytic, but has only weak or no myorelaxant and sedative activities. Partial agonists require higher fractional receptor occupancy than full agonists to elicit a given response in vivo. In the presence of full agonists, partial agonists compete for the receptor and may attenuate the actions of full agonists, indicating that partial agonists can exhibit antagonistic effects in those circumstances where they display limited or no effect. For example, numerous studies have shown that partial agonists antagonized sedation and muscle relaxation induced by full agonists. b-Carboline abecarnil showed differences in subtype-selectivity and intrinsic efficacy. Several studies in rodents have indicated that abecarnil produced clear anxiolytic-like effects. [15] [16] [17] Active ingredients isolated from several traditional sedatives, such as chrysin (5,7-dihydroxyflavone), miltron and apigenin (5,7,4Ј-trihydroxyflavone) showed partial agonistic activity to the central type of benzodiazepine receptor. Among these, apigenin and synthetic 6,3Ј-dinitroflavone and 6-bromoflavone have been proposed to have selective anxiolytic activities, and have been adopted by medicinal chemists to improve their activities for better clinical efficacy. 4, 5, 9, 10) In this study, mice treated with an 80% methanol extract of Fossilia Mastodi OSSIS exhibited anxiolysis in the elevated plus maze like mice on diazepam, a known synthetic anxiolytic-sedative. Benzodiazepines including diazepam are known to have pharmacological activities mediated via allosteric potentiation of GABA A receptor function. Fossilia reversed the anxiolysis induced by picrotoxin, a GABA A receptor antagonist, however, it potentiated the anxiolysis induced by muscimol, a GABA A receptor agonist. From these data, it can be concluded that a GABA A receptor mediated the anxiolytic effects of Fossilia. Like diazepam, Fossilia enhanced pentobarbital-induced sleeping time, and reduced locomotor activity. However, the activities of Fossilia were not as great as those of diazepam. Furthermore, Fossilia did not show prominent anticonvulsant and myorelaxant activities. Diazepam, a full agonist of the benzodiazepine receptor, exhibits a wide spectrum of pharmacological activities, including anticonvulsion and myorelaxation activity.
From the data obtained in this study, the methanol extract of Fossilia Mastodi OSSIS may be proposed as a source of natural sedative. Partial agonistic and/or subtype-selective modulation to GABA A receptosr by the ingredients of Fossilia may be hypothesized from this study. Prolonged modification of organic materials of extinct mammals induced by microorganisms in the soil, could be postulated as an explanation for the production of biologically active substances. Further investigations on clarification of the action mechanism and identification of some biologically active principles with sedative activity need to be done before practical use is considered.
